NCT00628199
Study to Create Potential Cell-Based Therapies to Treat Human Disease and Disability
Enrolling by Invitation
Not specifiedAges 1–75ObservationalStanford UniversityInvestigator-initiated
~60 participants
Updated 2022-08-12 on ClinicalTrials.gov
What's tested:Improving the scientific process of human cell reprogramming
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
A primary outcome measure isn't published for this study.
Conditions
Where it's being run
1 sites across 1 statesCalifornia1
Study leadership
- Marius Wernig, MD · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov